Trust Company of the South’s Pfizer PFE Stock Holding History

Trust Company of the South’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$473K	Sell	19,627 -2,539	-11%	-$66.4K	0.07%	90
2026 Q1	$622K	Buy	22,166 +8,904	+67%	+$237K	0.1%	71
2025 Q4	$330K	Sell	13,262 -1,106	-8%	-$27.9K	0.05%	104
2025 Q3	$366K	Sell	14,368 -15,018	-51%	-$371K	0.06%	98
2025 Q2	$712K	Buy	29,386 +441	+2%	+$10.3K	0.13%	60
2025 Q1	$733K	Hold	28,945	–	–	0.15%	59
2024 Q4	$768K	Buy	28,945 +1,667	+6%	+$45.2K	0.16%	61
2024 Q3	$789K	Sell	27,278 -50	-0.2%	-$1.46K	0.17%	60
2024 Q2	$765K	Sell	27,328 -54	-0.2%	-$1.49K	0.18%	54
2024 Q1	$760K	Sell	27,382 -481	-2%	-$13.3K	0.18%	56
2023 Q4	$802K	Buy	+27,863	New	+$842K	0.21%	50

Other funds holding PFE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Trust Company of the South's PFE Position: Q2 2026 in Review

Trust Company of the South reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $66.4K and leaving 19,627 shares worth $473K. The position accounts for 0.07% of the portfolio, ranked #90.

Trust Company of the South first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $802K in Q4 2023. 1,698 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Trust Company of the South held 19,627 shares of Pfizer worth $473K as of Q2 2026.
Trust Company of the South sold 2,539 Pfizer shares in Q2 2026, an estimated $66.4K.
Pfizer made up 0.07% of Trust Company of the South's portfolio in Q2 2026, its #90 holding.
Trust Company of the South first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Trust Company of the South's Pfizer position peaked at $802K in Q4 2023.
1,698 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.